Myomo lidera a los ganadores de atención médica; SELLAS Life Sciences y NanoViricides entre perdedores
Ganadores : Myomo (NYSEMKT: MYO ) + 49% . Viveve Medical (NASDAQ: VIVE ) + 32% . Arcus Biosciences (NYSE: RCUS ) + 24% . Can-Fite BioPharma (NYSEMKT: CANF ) + 24% . Evelo Biosciences (NASDAQ: EVLO ) + 23% .
Perdedores: Genprex (NASDAQ: GNPX ) -17% . SELLAS Life Sciences (NASDAQ: SLS ) -13% . Eton Pharmaceuticals (NASDAQ: ETON ) -11% . NanoViricidas (NYSEMKT: NNVC ) -10% . Cellectar Biosciences (NASDAQ: CLRB ) -10% .
